Upper respiratory tract microbiome profiles in SARS-CoV-2 Delta and Omicron infected patients exhibit variant specific patterns and robust prediction of disease groups/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Folakunmi on 2024-3-29

Curated date: 2024/03/12

Curator: ModinatG

Revision editor(s): ModinatG, Folakunmi

Subjects

Location of subjects
India
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Upper respiratory tract Upper respiratory tract,upper respiratory tract
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
SARS-CoV-2-related disease COVID-19-related disease,SARS-CoV-2-related disease,sARS-CoV-2-related disease
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
COVID-19 patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients infected with COVID-19 virus (Delta and Omicron)
Group 0 sample size Number of subjects in the control (unexposed) group
19
Group 1 sample size Number of subjects in the case (exposed) group
43
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
1 month

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
3

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Chao1 Abundance-based estimator of species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
decreased

Signature 1

Reviewed Marked as Reviewed by Folakunmi on 2024-3-28

Curated date: 2024/03/12

Curator: ModinatG

Revision editor(s): ModinatG, Folakunmi

Source: FIG 2

Description: LEfSe analysis of core species of COVID-19 patients and healthy controls.

Abundance in Group 1: increased abundance in COVID-19 patients

NCBI Quality ControlLinks
Stenotrophomonas maltophilia
Pseudoalteromonas shioyasakiensis
Pseudoalteromonas gelatinilytica
Ochrobactrum sp.
Stenotrophomonas sp.
Pseudomonas sp.
Staphylococcus caprae
Rheinheimera pleomorphica
Vibrio tritonius
Chryseobacterium sp.
Vreelandella piezotolerans
Pelagibacterium halotolerans
Pseudomonas aeruginosa

Revision editor(s): ModinatG, Folakunmi

Signature 2

Reviewed Marked as Reviewed by Folakunmi on 2024-3-28

Curated date: 2024/03/12

Curator: ModinatG

Revision editor(s): ModinatG, Folakunmi

Source: FIG 2

Description: Relative abundances of bacteria in upper respiratory tract (URT) of Covid-19 patients and healthy group

Abundance in Group 1: decreased abundance in COVID-19 patients

NCBI Quality ControlLinks
Bifidobacterium longum
Fusobacterium pseudoperiodonticum
Haemophilus parainfluenzae
Neisseria perflava
Prevotella melaninogenica
Streptococcus symci
Veillonella nakazawae
Veillonella tobetsuensis
Actinobacillus sp.
Corynebacterium accolens
Moraxella equi
Streptococcus toyakuensis
Veillonella rogosae
Neisseria subflava
Leptotrichia wadei
Veillonella atypica

Revision editor(s): ModinatG, Folakunmi